Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70416-0 ◽

2007 ◽

Vol 2007 ◽

pp. 198-203

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Single Agent ◽

Locally Advanced ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text

Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)]: Final results of a randomized phase III trial in stage III unresectable non small cell lung (NSCLC) cancer. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7016 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7016-7016 ◽

Author(s):

R. Gervais ◽

A. Ducolone ◽

T. Lechevalier ◽

A. Legroumellec ◽

E. Lemarie ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Conventional Radiation

Download Full-text

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group

European Journal of Cancer ◽

10.1016/j.ejca.2011.03.035 ◽

2011 ◽

Vol 47 (10) ◽

pp. 1546-1555 ◽

Author(s):

Andrea Koch ◽

Bengt Bergman ◽

Erik Holmberg ◽

Christer Sederholm ◽

Lars Ek ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Double Blind ◽

Phase Iii Trial ◽

Clinical Phase ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text

Paclitaxel/carboplatin (PC) followed by twice daily chemoradiation (hfRT/PC) versus hfRT/PC followed by PC as induction to surgery in stage III non-small cell lung cancer (NSCLC): A randomized phase III trial of the Lung Cancer Study Group Mitteldeutschland

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7541 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7541-7541 ◽

Author(s):

R. Bonnet ◽

C. P. Schneider ◽

T. G. Wendt ◽

N. Presselt ◽

R. P. Baum ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text

Gemcitabine versus gemcitabine/carboplatin in advanced non–small cell lung cancer: Preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group

Seminars in Oncology ◽

10.1053/sonc.2002.34276 ◽

2002 ◽

Vol 29 (3) ◽

pp. 50-54 ◽

Author(s):

Christer Sederholm

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text

Phase II study of cisplatin (CDDP) and 5-fluorouracil (5-FU) with concurrent hyperfractionated thoracic radiotherapy (HFTRT) for locally advanced non-small-cell lung cancer (LA-NSCLC): A preliminary report from the Okayama Lung Cancer Study Group

Lung Cancer ◽

10.1016/s0169-5002(00)80385-2 ◽

2000 ◽

Vol 29 (1) ◽

pp. 116-117

Author(s):

Y Segawa ◽

H Ueoka ◽

K Kiura ◽

K Sakae ◽

Y Hiraki ◽

...

Keyword(s):

Lung Cancer ◽

Preliminary Report ◽

Phase Ii Study ◽

Locally Advanced ◽

Study Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text

Faculty Opinions recommendation of Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10187956.10976054 ◽

2011 ◽

Author(s):

Elizabeth Gore

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Concurrent Chemoradiotherapy ◽

Locally Advanced ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Download Full-text

Three-arm randomized trial of sodium alginate, orally administered mucoprotective agent, for preventing radiation esophagitis in pts with locally advanced non-small-cell lung cancer (LA-NSCLC) receiving concurrent chemoradiotherapy (CRT): Okayama Lung Cancer Study Group 1401.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps9641 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS9641-TPS9641

Author(s):

Katsuyuki Hotta ◽

Kiichiro Ninomiya ◽

Isao Oze ◽

Akihiro Bessho ◽

Toshi Murakami ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Locally Advanced ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Radiation Esophagitis

Download Full-text

A Phase II Study of Cisplatin (P), S-1 (S) and Concurrent Thoracic Radiotherapy (TRT) for Locally Advanced Non-Small-Cell Lung Cancer (LA-NSCLC): Okayama Lung Cancer Study Group Trial 0501

Annals of Oncology ◽

10.1016/s0923-7534(20)32313-9 ◽

2012 ◽

Vol 23 ◽

pp. xi115

Author(s):

N. Nogami ◽

T. Kozuki ◽

Y. Segawa ◽

T. Shinkai ◽

T. Maeda ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Study Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Download Full-text

O-097 A randomized phase III trial of six versus four cycles ofchemotherapy: Optimal duration of chemotherapy in advanced non-small-cell lung cancer: Korea cancer study group experience

Lung Cancer ◽

10.1016/s0169-5002(05)80231-4 ◽

2005 ◽

Vol 49 ◽

pp. S34-S35 ◽

Author(s):

J. Park ◽

S. Kim ◽

J. Jang ◽

E. Cho ◽

S. Yang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group ◽

Optimal Duration ◽

Group Experience

Download Full-text

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group

Lung Cancer ◽

10.1016/0169-5002(92)90074-t ◽

1992 ◽

Vol 8 (3-4) ◽

pp. 241

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Randomized Study ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group

Download Full-text